**Key Updates** - **SOFTCARE (02698)**: Hong Kong public offering oversubscribed by 1,813.77 times, expected to list on November 10. - **HENGRUI PHARMA (01276)**: HRS-2430 and SHR-4610 injections receive clinical trial approval notices. - **LEADS BIOLABS-B (09887)**: Included in the MSCI Global Small Cap Index.
**Financial Data** - **FIH (02038)**: Anticipates annual revenue growth of approximately 15% and significant improvement in financial performance. - **BOYAA (00434)**: Expects attributable profit growth of 105%–115% YoY for the first nine months.